Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
10.54
+0.31 (3.03%)
Jul 16, 2025, 10:23 AM - Market open
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $574.81 million as of July 16, 2025.
Market Cap
574.81M
Enterprise Value
96.43M
1-Year Change
n/a
Ranking
Category
Stock Price
10.54
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has decreased from $931.70M to $574.81M, a decrease of -38.30%. That is a compound annual growth rate of -43.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2025 | 557.91M | -41.14% |
| Dec 31, 2024 | 947.92M | 1.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.60B |
| Johnson & Johnson | 377.32B |
| AbbVie | 338.30B |
| Novo Nordisk | 308.09B |
| UnitedHealth Group | 272.67B |
| Novartis AG | 237.08B |
| Abbott Laboratories | 229.71B |
| AstraZeneca | 222.35B |